Kasugamycin resistance: 30S ribosomal mutation with an unusual location on the Escherichia coli chromosome

Science
P F Sparling

Abstract

A mutation in Escherichia coli to resistance to the aminoglycoside antibiotic kasugamycin alters the 30S ribosomal subunit. Though all other known 30S ribosomal mutations are located in a cluster in the streptomycin region, kasugamycin resistance is located at a distance from this region, near the leucine region.

References

Oct 14, 1967·Journal of Molecular Biology·P AndersonB D Davis
Jan 1, 1968·The Journal of Antibiotics·H UmezawaR Utahara
Dec 1, 1967·Bacteriological Reviews·A L Taylor, C D Trotter
Jan 1, 1968·The Journal of Antibiotics·H MasukawaH Umezawa
Oct 1, 1966·Journal of Biochemistry·N TanakaH Umezawa
Apr 1, 1964·Proceedings of the National Academy of Sciences of the United States of America·J E DAVIES

❮ Previous
Next ❯

Citations

Jan 1, 1980·Molecular & General Genetics : MGG·O S Andrésson, J E Davies
Sep 26, 2006·Nature Structural & Molecular Biology·Barbara S SchuwirthAntón Vila-Sanjurjo
Jan 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·R A ZimmermannP F Sparling
Apr 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·J Shine, L Dalgarno
Mar 29, 2007·Nucleic Acids Research·Petr V SergievOlga A Dontsova
Feb 3, 2009·Nucleic Acids Research·Matthew R BakerJason P Rife
Apr 21, 2009·Trends in Biochemical Sciences·Keith Connolly, Gloria Culver
Dec 23, 2008·International Journal of Antimicrobial Agents·Paul M Duffin, H Steven Seifert
Nov 8, 2008·Molecular Microbiology·Keith ConnollyGloria Culver
Sep 14, 1972·Journal of Molecular Biology·M Kozak, D Nathans
Nov 15, 2011·Journal of Molecular Biology·Georgeta N BastureaKenneth E Rudd
Aug 5, 2015·The Journal of Clinical Investigation·P Frederick Sparling
Oct 8, 1999·Journal of Molecular Biology·A Vila-SanjurjoA E Dahlberg
Oct 8, 1974·Biochemical and Biophysical Research Communications·A OkuyamaN Tanaka
Aug 19, 1976·Molecular & General Genetics : MGG·W S Champney, S R Kushner
Jan 1, 1975·Molecular & General Genetics : MGG·R T Garvin, L Gorini
Mar 1, 1976·Bacteriological Reviews·B J BachmannA L Taylor
Feb 1, 1973·Journal of Bacteriology·P F SparlingD Elliot
Mar 1, 1972·Bacteriological Reviews·M Kozak, D Nathans
Jun 1, 1970·Bacteriological Reviews·A L Taylor
Sep 1, 1970·Bacteriological Reviews·M Nomura
Oct 1, 1973·Journal of Bacteriology·P F Sparling, E Blackman
Sep 1, 2008·EcoSal Plus·Katherine S Long, Birte Vester

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.